Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Čiháková

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Circulation|December 28, 2023
T Cells and Macrophages Drive Pathogenesis of Immune Checkpoint Inhibitor MyocarditisDaniela Čiháková
Annals of the New York Academy of Sciences|May 23, 2013
Control of inflammatory heart disease by CD4+ T cellsJobert G Barin, Daniela Čiháková
JACC. Basic to Translational Science|August 9, 2021
Do Genes Influence Susceptibility to Myocarditis?Leslie T Cooper, Daniela Čiháková
Advances in Experimental Medicine and Biology|July 2, 2017
Cardiac Autoimmunity: MyocarditisWilliam Bracamonte-Baran, Daniela Čiháková
Immunological Reviews|February 19, 2026
Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor-Associated MyocarditisWonyoung Jo, Vivian Sun, Daniela Čiháková
Clinical Immunology (Orlando, Fla.)|November 30, 2016
Natural killer cells in inflammatory heart diseaseSuFey Ong, Noel R Rose, Daniela Čiháková
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
ReplyMegan Kay Wood, Taejoon Won, Daniela Čiháková
Frontiers in Immunology|May 13, 2017
Eosinophils in Autoimmune DiseasesNicola L Diny, Noel R Rose, Daniela Čiháková
Frontiers in Immunology|February 20, 2024
Immune checkpoint inhibitors associated cardiovascular immune-related adverse eventsWonyoung Jo, Taejoon Won, Abdel Daoud, et al.
Cytokine|February 5, 2015
The varying faces of IL-6: From cardiac protection to cardiac failureJillian A Fontes, Noel R Rose, Daniela Čiháková
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Circulation|December 28, 2023
T Cells and Macrophages Drive Pathogenesis of Immune Checkpoint Inhibitor MyocarditisDaniela Čiháková
Annals of the New York Academy of Sciences|May 23, 2013
Control of inflammatory heart disease by CD4+ T cellsJobert G Barin, Daniela Čiháková
JACC. Basic to Translational Science|August 9, 2021
Do Genes Influence Susceptibility to Myocarditis?Leslie T Cooper, Daniela Čiháková
Advances in Experimental Medicine and Biology|July 2, 2017
Cardiac Autoimmunity: MyocarditisWilliam Bracamonte-Baran, Daniela Čiháková
Immunological Reviews|February 19, 2026
Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor-Associated MyocarditisWonyoung Jo, Vivian Sun, Daniela Čiháková
Clinical Immunology (Orlando, Fla.)|November 30, 2016
Natural killer cells in inflammatory heart diseaseSuFey Ong, Noel R Rose, Daniela Čiháková
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
ReplyMegan Kay Wood, Taejoon Won, Daniela Čiháková
Frontiers in Immunology|May 13, 2017
Eosinophils in Autoimmune DiseasesNicola L Diny, Noel R Rose, Daniela Čiháková
Frontiers in Immunology|February 20, 2024
Immune checkpoint inhibitors associated cardiovascular immune-related adverse eventsWonyoung Jo, Taejoon Won, Abdel Daoud, et al.
Cytokine|February 5, 2015
The varying faces of IL-6: From cardiac protection to cardiac failureJillian A Fontes, Noel R Rose, Daniela Čiháková
Pageof 5